Literature DB >> 23529746

Chinese medicine for treating diabetic nephropathy.

Bin Wang1, Lan Lin, Qing Ni, Cheng-lian Su.   

Abstract

Diabetic nephropathy is one of the main causes of renal end-stage disease. The pathogenesis of diabetic nephropathy is complex. The current treatment is only for a particular cause without multi-target therapeutic drugs. Chinese medicine is a great treasure with multi-component complex drugs interacting with multiple targets and functions. This paper reviewed the protective effect of Chinese medicine for treating diabetic nephropathy in clinical studies, in vivo studies, and in vitro studies. The possible mechanisms, the major compounds and active crude drugs were also summarized. It was shown that Chinese medicine could not only relieve several symptoms and improve the quality of life, but also reduce the levels of proteinuria and kidney damage, and further improve renal function via multiple pathways based on the whole human system. Moreover, there were no reports of severe adverse reactions during the treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529746     DOI: 10.1007/s11655-011-0880-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  30 in total

1.  Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

Authors:  Takako Nakagawa; Takako Yokozawa; Katsutoshi Terasawa; Kazuo Nakanishi
Journal:  J Pharm Pharmacol       Date:  2003-02       Impact factor: 3.765

2.  Water extract of the root of Lindera strychnifolia slows down the progression of diabetic nephropathy in db/db mice.

Authors:  Takamasa Ohno; Genzou Takemura; Ichijiro Murata; Tomoyo Kagawa; Seigo Akao; Shinya Minatoguchi; Takako Fujiwara; Hisayoshi Fujiwara
Journal:  Life Sci       Date:  2005-08-05       Impact factor: 5.037

3.  Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats.

Authors:  Y-W Zhang; D Xie; Y-X Chen; H-Y Zhang; Z-X Xia
Journal:  Exp Clin Endocrinol Diabetes       Date:  2006-11       Impact factor: 2.949

4.  [Effect of liuwei dihuang pill on erythrocyte aldose reductase activity in early diabetic nephropathy patients].

Authors:  Xiao-Yan Song; Qiang Chen; Xiao-Yan Qi
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2004-12

5.  Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats.

Authors:  Yu Cai; Jianwen Chen; JianMin Jiang; Weiwei Cao; Lan He
Journal:  J Ethnopharmacol       Date:  2010-06-12       Impact factor: 4.360

6.  KIOM-79 prevents S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells.

Authors:  Dong Ho Jung; Young Sook Kim; Jin Sook Kim
Journal:  J Ethnopharmacol       Date:  2009-08-08       Impact factor: 4.360

7.  Chinese prescription Kangen-karyu prevents dyslipidaemia and oxidative stress in mouse model of type 2 diabetes.

Authors:  Jeong Sook Noh; Chan Hum Park; Hyun Young Kim; Qi Zhao; Noriko Yamabe; Kinzo Matsumoto; Takako Yokozawa
Journal:  J Pharm Pharmacol       Date:  2010-10-11       Impact factor: 3.765

8.  Garlic extract reduces serum angiotensin converting enzyme (ACE) activity in nondiabetic and streptozotocin-diabetic rats.

Authors:  Mahmoud Hosseini; S Mohammad Shafiee; Tourandokht Baluchnejadmojarad
Journal:  Pathophysiology       Date:  2007-09-17

9.  Renal oxidative stress and nitric oxide production in streptozotocin-induced diabetic nephropathy in rats: the possible modulatory effects of garlic (Allium sativum L.).

Authors:  Amr D Mariee; Gamil M Abd-Allah; Mohamad F El-Yamany
Journal:  Biotechnol Appl Biochem       Date:  2009-03       Impact factor: 2.431

10.  Ethanol extracts of Rehmannia complex (Di Huang) containing no Corni fructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats.

Authors:  Hao-Ran Liu; Xiao-Yun Tang; De-Zai Dai; Yin Dai
Journal:  J Ethnopharmacol       Date:  2008-05-23       Impact factor: 4.360

View more
  2 in total

1.  BOLD MRI to evaluate early development of renal injury in a rat model of diabetes.

Authors:  Qidong Wang; Chuangen Guo; Lan Zhang; Rui Zhang; Zhaoming Wang; Ying Xu; Wenbo Xiao
Journal:  J Int Med Res       Date:  2018-02-15       Impact factor: 1.671

2.  Mechanism of Astragalus membranaceus Alleviating Acquired Hyperlipidemia Induced by High-Fat Diet through Regulating Lipid Metabolism.

Authors:  Ling Wang; Wenya Zheng; Jinxin Yang; Anwar Ali; Hong Qin
Journal:  Nutrients       Date:  2022-02-23       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.